Search alternatives:
"b marked decrease" » "b marked increase" (Expand Search), "_ marked decrease" (Expand Search), "a marked decrease" (Expand Search), "n marked decrease" (Expand Search)
"c large decrease" » "c large increases" (Expand Search), "c large degree" (Expand Search), "_ large decrease" (Expand Search), "a large decrease" (Expand Search), "b large decrease" (Expand Search)
"c larger decrease" » "_ larger decrease" (Expand Search), "_ large decrease" (Expand Search), "a large decrease" (Expand Search), "a larger decrease" (Expand Search), "b larger decrease" (Expand Search)
"b marked decrease" » "b marked increase" (Expand Search), "_ marked decrease" (Expand Search), "a marked decrease" (Expand Search), "n marked decrease" (Expand Search)
"c large decrease" » "c large increases" (Expand Search), "c large degree" (Expand Search), "_ large decrease" (Expand Search), "a large decrease" (Expand Search), "b large decrease" (Expand Search)
"c larger decrease" » "_ larger decrease" (Expand Search), "_ large decrease" (Expand Search), "a large decrease" (Expand Search), "a larger decrease" (Expand Search), "b larger decrease" (Expand Search)
-
1
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
2
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
3
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
4
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
5
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
6
The spatial distribution of Bgs4 in <i>ync13</i><i>Δ</i> cells depends on Rng10.
Published 2025“…Arrows in <b>(A)</b> mark Ags1 concentrated at the center of the division plane after ring constriction and in <b>(B)</b> mark decreased Bgs4 level at the septal edges. <b>(D</b> and <b>E)</b> Gaussian fits of fluorescence intensity of Bgs4 <b>(D)</b> and Bgs1 <b>(E)</b> along the division site at the end of ring constriction in WT or <i>ync13Δ</i> cells. …”